Beacon Investment Advisory Services Inc. boosted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 3.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,459 shares of the financial services provider’s stock after acquiring an additional 83 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in CME Group were worth $543,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently added to or reduced their stakes in the business. Ameriprise Financial Inc. grew its stake in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares during the last quarter. Raymond James & Associates boosted its stake in shares of CME Group by 3.2% during the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after purchasing an additional 94,302 shares during the last quarter. Legal & General Group Plc boosted its stake in shares of CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after purchasing an additional 176,004 shares during the last quarter. PineStone Asset Management Inc. boosted its stake in shares of CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of CME Group by 1.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,981,961 shares of the financial services provider’s stock worth $437,320,000 after purchasing an additional 26,642 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms have issued reports on CME. The Goldman Sachs Group raised their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. TD Cowen began coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 price target on the stock. Bank of America raised their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Morgan Stanley raised their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Finally, Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average target price of $224.47.
CME Group Trading Down 1.0 %
NASDAQ CME opened at $235.61 on Tuesday. CME Group Inc. has a one year low of $190.70 and a one year high of $238.97. The company’s 50 day moving average price is $225.55 and its 200 day moving average price is $211.96. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market capitalization of $84.90 billion, a price-to-earnings ratio of 24.77, a PEG ratio of 5.49 and a beta of 0.55.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. On average, sell-side analysts predict that CME Group Inc. will post 10.22 EPS for the current year.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is currently 48.37%.
Insider Transactions at CME Group
In other CME Group news, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 14.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the transaction, the director now directly owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,028 shares of company stock valued at $1,811,681. 0.30% of the stock is currently owned by corporate insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- Best Aerospace Stocks Investing
- How to Master Trading Discipline: Overcome Emotional Challenges
- Market Cap Calculator: How to Calculate Market Cap
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- P/E Ratio Calculation: How to Assess Stocks
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.